Kangyuan Pharmaceutical: 6 executives intend to increase their holdings of no less than 120,000 shares.

Announcement from Kangyuan Pharmaceuticals: Directors and General Managers Yang Yongchun, Gao Haixin, Chen Xuebin, Liu Quan, Wang Chuanlei, and Pan Yu plan to increase their holdings by a total of no less than 120,000 shares through centralized bidding on the Shanghai Stock Exchange with their own funds starting from November 10, 2025, for a period of one month. Each person's increase in holdings will not be less than 20,000 shares. There is no price range set for this increase plan, and they commit not to reduce their holdings during the implementation period and the statutory period.